Mircea BEZERGHEANU / Shutterstock.com
Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Aurobindo, Shionogi, Doribax, ANDA, US District Court for the Northern District of Illinois, doripenem